UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 47

Sortiert nach

Role of CXCR4 in the pathogenesis of acute myeloid leukemia

Theranostics, 2013-01, Vol.3 (1), p.34-39

2013

Volltextzugriff (PDF)

Can inhibition of the SDF-1/CXCR4 axis eradicate acute leukemia?

Seminars in cancer biology, 2010-06, Vol.20 (3), p.178-185

2010

Volltextzugriff (PDF)

The ability to cross the blood–cerebrospinal fluid barrier is a generic property of acute lymphoblastic leukemia blasts

Blood, 2016-04, Vol.127 (16), p.1998-2006

2016

Volltextzugriff (PDF)

CXCR4 regulates migration and development of human acute myelogenous leukemia stem cells in transplanted NOD/SCID mice

Cancer research (Chicago, Ill.), 2004-04, Vol.64 (8), p.2817-2824

2004

Volltextzugriff (PDF)

Anti-platelet factor 4/heparin antibodies from patients with heparin-induced thrombocytopenia provoke direct activation of microvascular endothelial cells

International immunology, 2002-02, Vol.14 (2), p.121-129

2002

Volltextzugriff (PDF)

Motility, proliferation, and egress to the circulation of human AML cells are elastase dependent in NOD/SCID chimeric mice

Blood, 2005-09, Vol.106 (6), p.2120-2127

2005

Volltextzugriff (PDF)

Mutations of the CHK2 gene are found in some osteosarcomas, but are rare in breast, lung, and ovarian tumors

Genes chromosomes & cancer, 2002-01, Vol.33 (1), p.17-21

2002

Volltextzugriff (PDF)

Anti-endothelial cell antibodies from patients with thrombotic thrombocytopenic purpura specifically activate small vessel endothelial cells

International immunology, 2001-02, Vol.13 (2), p.203-210

2001

Volltextzugriff (PDF)

Clinical Predictors for Relapse Among Patients with AML Who Responded to Venetoclax-Based Treatment - a Real-World Prospective Analysis from the Revive Study Group

Blood, 2022-11, Vol.140 (Supplement 1), p.9002-9004

2022

Volltextzugriff (PDF)

Utilization of Antifungal Prophylaxis and Treatment for Newly Diagnosed AML Patients Treated with Venetoclax Based Regimens in Routine Clinical Practice - a Prospective Analysis from the Revive Study

Blood, 2022-11, Vol.140 (Supplement 1), p.6162-6164

2022

Volltextzugriff (PDF)

Tyrosine kinase inhibitors induced immune thrombocytopenia in chronic myeloid leukemia?

Hematology reports, 2011-12, Vol.3 (3), p.e29-e29

2011

Volltextzugriff (PDF)

Real World Prospective Observational Multicenter Trial of Venetoclax-Based Therapy for Patients with AML Reveals Unique Patterns of Patient Selection and Treatment Utilization - Revive Study

Blood, 2021-11, Vol.138 (Supplement 1), p.1246-1246

2021

Volltextzugriff (PDF)

Dasatinib Inhibits FLT3/ITD and PTPN11mutated Acute Myeloid Leukemia Cells Overexpressing SRC Tyrosine Kinases

Blood, 2019-11, Vol.134 (Supplement_1), p.1451-1451

2019

Volltextzugriff (PDF)

The Pattern of Use of PET/CT Scans in the Clinical Management of Chronic Lymphocytic Leukemia

Clinical lymphoma, myeloma and leukemia, 2021-08, Vol.21 (8), p.558-563

2021

Volltextzugriff (PDF)

First Results from a Nationwide Prospective Non-Interventional Study of Venetoclax-Based 1st Line Therapies in Patients with Acute Myeloid Leukemia (AML) - Revive Study

Blood, 2020-11, Vol.136 (Supplement 1), p.27-28

2020

Volltextzugriff (PDF)

Dasatinib response in acute myeloid leukemia is correlated with FLT3/ITD, PTPN11 mutations and a unique gene expression signature

Haematologica (Roma), 2020-12, Vol.105 (12), p.2795

2020

Volltextzugriff (PDF)

Mutation analysis of the DNA-damage checkpoint gene CHK2 in myelodysplastic syndromes and acute myeloid leukemias

Leukemia research, 2001-04, Vol.25 (4), p.333-338

2001

Volltextzugriff (PDF)

The CXCR4 Antagonist BL-8040 Efficiently Induces Apoptosis and Inhibits The Survival Of AML Cells

Blood, 2013-11, Vol.122 (21), p.3939-3939

2013

Volltextzugriff (PDF)

Ruxolitinib treatment for myelofibrosis: Efficacy and tolerability in routine practice

Leukemia research, 2015-11, Vol.39 (11), p.1154-1158

2015

Volltextzugriff (PDF)

Abstract 4430: Loss of the histone methyltransferase EZH2 induces chemoresistance in acute myeloid leukemia (AML)

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.4430-4430

2015

Volltextzugriff (PDF)

Loss Of H3K27 Trimethylation (H3K27me3) Associates With a Multi Drug Resistance Phenotype In Acute Myeloid Leukemia (AML)

Blood, 2013-11, Vol.122 (21), p.1253-1253

2013

Volltextzugriff (PDF)

Ruxolitinib Treatment for Myelofibrosis: Efficacy and Tolerability in a Real-World Setting

Blood, 2014-12, Vol.124 (21), p.1830-1830

2014

Volltextzugriff (PDF)

Analysis of the CHK2 Gene in Lymphoid Malignancies

Leukemia & lymphoma, 2001, Vol.42 (3), p.517-520

2001

Volltextzugriff (PDF)

Mesenchymal stromal cells revert multiple myeloma cells to less differentiated phenotype by the combined activities of adhesive interactions and interleukin-6

Experimental cell research, 2009-07, Vol.315 (11), p.1904-1913

2009

Volltextzugriff (PDF)

1 – 25 von 47

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(44)

Publikationsform

Artikel
(46)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(25)
Science & Technology
(25)
Humans
(24)
Oncology
(16)
Hematology
(13)
Animals
(11)
Female
(9)
Male
(8)
Mice
(8)
Aged
(6)
Biological And Medical Sciences
(6)
Middle Aged
(6)
Cell Line, Tumor
(5)
Hematology, Oncology And Palliative Medicine
(5)
Leukemia, Myeloid, Acute - Drug Therapy
(5)
Medical Sciences
(5)
Adult
(4)
Aged, 80 And Over
(4)
Hematologic And Hematopoietic Diseases
(4)
Leukemia, Myeloid, Acute - Pathology
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Role of CXCR4 in the pathogenesis of acute myeloid leukemia

Loss of the histone methyltransferase EZH2 induces resistance to multiple drugs in acute myeloid leukemia

Can inhibition of the SDF-1/CXCR4 axis eradicate acute leukemia?

The ability to cross the blood–cerebrospinal fluid barrier is a generic property of acute lymphoblastic leukemia blasts

CXCR4 regulates migration and development of human acute myelogenous leukemia stem cells in transplanted NOD/SCID mice

Anti-platelet factor 4/heparin antibodies from patients with heparin-induced thrombocytopenia provoke direct activation of microvascular endothelial cells

Motility, proliferation, and egress to the circulation of human AML cells are elastase dependent in NOD/SCID chimeric mice

Mutations of the CHK2 gene are found in some osteosarcomas, but are rare in breast, lung, and ovarian tumors

Anti-endothelial cell antibodies from patients with thrombotic thrombocytopenic purpura specifically activate small vessel endothelial cells

Clinical Predictors for Relapse Among Patients with AML Who Responded to Venetoclax-Based Treatment - a Real-World Prospective Analysis from the Revive Study Group

Utilization of Antifungal Prophylaxis and Treatment for Newly Diagnosed AML Patients Treated with Venetoclax Based Regimens in Routine Clinical Practice - a Prospective Analysis from the Revive Study

Tyrosine kinase inhibitors induced immune thrombocytopenia in chronic myeloid leukemia?

Real World Prospective Observational Multicenter Trial of Venetoclax-Based Therapy for Patients with AML Reveals Unique Patterns of Patient Selection and Treatment Utilization - Revive Study

Dasatinib Inhibits FLT3/ITD and PTPN11mutated Acute Myeloid Leukemia Cells Overexpressing SRC Tyrosine Kinases

The Pattern of Use of PET/CT Scans in the Clinical Management of Chronic Lymphocytic Leukemia

First Results from a Nationwide Prospective Non-Interventional Study of Venetoclax-Based 1st Line Therapies in Patients with Acute Myeloid Leukemia (AML) - Revive Study

Dasatinib response in acute myeloid leukemia is correlated with FLT3/ITD, PTPN11 mutations and a unique gene expression signature

Mutation analysis of the DNA-damage checkpoint gene CHK2 in myelodysplastic syndromes and acute myeloid leukemias

The CXCR4 Antagonist BL-8040 Efficiently Induces Apoptosis and Inhibits The Survival Of AML Cells

Ruxolitinib treatment for myelofibrosis: Efficacy and tolerability in routine practice

Abstract 4430: Loss of the histone methyltransferase EZH2 induces chemoresistance in acute myeloid leukemia (AML)

Loss Of H3K27 Trimethylation (H3K27me3) Associates With a Multi Drug Resistance Phenotype In Acute Myeloid Leukemia (AML)

Ruxolitinib Treatment for Myelofibrosis: Efficacy and Tolerability in a Real-World Setting

Analysis of the CHK2 Gene in Lymphoid Malignancies

Mesenchymal stromal cells revert multiple myeloma cells to less differentiated phenotype by the combined activities of adhesive interactions and interleukin-6

Suchergebnisse filtern